1-5 of 5
Ming-Cheng Lee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia

Chieh-Lung Cheng, Hsin-An Hou, Ming-Cheng Lee, Chieh-Yu Liu, Jie-Yang Jhuang, Yan-Jun Lai, Chung-Wu Lin, Huan-Yuan Chen, Fu-Tong Liu, Wen-Chien Chou, Chien-Yuan Chen, Jih-Luh Tang, Ming Yao, Shang-Yi Huang, Bor-Sheng Ko, Shang-Ju Wu, Woei Tsay, Hwei-Fang Tien
Journal: Blood
Blood (2013) 121 (16): 3172–3180.
https://doi.org/10.1182/blood-2012-07-443762
Published: 2013
Includes: Supplemental data
Journal Articles

DNMT3A mutations in De Novo Myelodysplastic Syndrome: Distinct Clinico-Biological Features and Prognostic Relevance

Ming-En Lin, MD, Hsin-An Hou, MD, Yuan-Yeh Kuo, PhD, Wen-Chien Chou, MD, PhD, Ming Cheng Lee, Chien-Yuan Chen, MD, Yan-Jun Lai, Mei-Hsuan Tseng, Chi-Fei Huang, Ying-Chieh Chiang, Fen-Yu Lee, Ming-Chih Liu, Chia-Wen Liu, Jih-Luh Tang, MD, PhD, Ming Yao, MD, Shang-Yi Huang, MD, PhD, Bor-Sheng Ko, MD, Szu-Chun Hsu, MD, Shang-Ju Wu, MD, Woei Tsay, MD, PhD, Yao-Chang Chen, MD, PhD, Hwei-Fang Tien, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3799.
https://doi.org/10.1182/blood.V120.21.3799.3799
Published: 2012
Journal Articles

DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications

Hsin-An Hou, Yuan-Yeh Kuo, Chieh-Yu Liu, Wen-Chien Chou, Ming Cheng Lee, Chien-Yuan Chen, Liang-In Lin, Mei-Hsuan Tseng, Chi-Fei Huang, Ying-Chieh Chiang, Fen-Yu Lee, Ming-Chih Liu, Chia-Wen Liu, Jih-Luh Tang, Ming Yao, Shang-Yi Huang, Bor-Sheng Ko, Szu-Chun Hsu, Shang-Ju Wu, Woei Tsay, Yao-Chang Chen, Hwei-Fang Tien
Journal: Blood
Blood (2012) 119 (2): 559–568.
https://doi.org/10.1182/blood-2011-07-369934
Published: 2012
Includes: Supplemental data
Journal Articles

DNMT3A Mutations in Acute Myeloid Leukemia-Stability During Disease Evolution and the Clinical Implication

Hsin-An Hou, MD, Yuan-Yeh Kuo, Chieh-Yu Liu, Wen-Chien Chou, MD, PhD, Ming Cheng Lee, Chien-Yuan Chen, Liang-In Lin, PhD, Mei-Hsuan Tseng, Chi-Fei Huang, Ying-Chieh Chiang, Fen-Yu Lee, Ming-Chih Liu, Chia-Wen Liu, Jih-Luh Tang, MD, PhD, Ming Yao, MD, Shang-Yi Huang, MD, PhD, Bor-Sheng Ko, Szu-Chun Hsu, Shang-Ju Wu, Woei Tsay, Yao-Chang Chen, Hwei-Fang Tien, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 409.
https://doi.org/10.1182/blood.V118.21.409.409
Published: 2011
Journal Articles

TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics

Clinical Trials & Observations
Wen-Chien Chou, Sheng-Chieh Chou, Chieh-Yu Liu, Chien-Yuan Chen, Hsin-An Hou, Yuan-Yeh Kuo, Ming-Cheng Lee, Bor-Sheng Ko, Jih-Luh Tang, Ming Yao, Woei Tsay, Shang-Ju Wu, Shang-Yi Huang, Szu-Chun Hsu, Yao-Chang Chen, Yi-Chang Chang, Yi-Yi Kuo, Kuan-Ting Kuo, Fen-Yu Lee, Ming-Chi Liu, Chia-Wen Liu, Mei-Hsuan Tseng, Chi-Fei Huang, Hwei-Fang Tien
Journal: Blood
Blood (2011) 118 (14): 3803–3810.
https://doi.org/10.1182/blood-2011-02-339747
Published: 2011
Includes: Supplemental data